Epi Labs Inc. funding
Epi Labs Inc., a biotechnology company based in San Francisco, CA (founded 2023), filed a Form D with the SEC on April 30, 2026 and reported $14.8M raised of a $16.1M offering.
Amount raised$14.8M
Offering size$16.1M
Filed with the SECApril 30, 2026
First saleApril 6, 2026
IndustryBiotechnology
SecuritiesEquity
LocationSan Francisco, CA
Founded2023
Entity typeCorporation
Investors so far15
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 30
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology